Sort
48,018 grants matching “immunotherapy”
Southwest Oncology Group
$387,405Saul Rivkin · Swedish Medical Center, First Hill · U10 · FY2011 · CA
Southwest Oncology Group
$387,405Saul Rivkin · Swedish Medical Center, First Hill · U10 · FY2010 · CA
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology
$387,403Gerard C Blobe · Duke University · R01 · FY2019 · CA
MEMORY T CELLS IN EAE
$387,391Samia J. Khoury · Brigham And Women'S Hospital · R01 · FY2011 · AI
MEMORY T CELLS IN EAE
$387,391Samia J. Khoury · Brigham And Women'S Hospital · R01 · FY2012 · AI
Matching genotypes with personalized therapies: Development of a decision support infrastructure to augment the value of precision medicine
$387,351Valsamo Anagnostou · Johns Hopkins University · U01 · FY2024 · CA
Vitamin B6 Modulates NK Cell Metabolism in Pancreatic Cancer
$387,341Kamiya Mehla · University Of Oklahoma Hlth Sciences Ctr · R37 · FY2025 · CA
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
$387,285Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Epigenetic Regulation of Plasma Cells Differentiation
$387,281Jeremy M. Boss · Emory University · R01 · FY2016 · AI
ADVANCING IMMUNOTHERAPY IN BREAST CANCER LOCAL REPROGRAMMING OF TUMOR-ASSOCIATED MACROPHAGES WITH NOVEL BIOMATERIALS FOR SYSTEMIC ADAPTIVE ANTICANCER
$387,268Vanderbilt University Medical Center · · FY2019 · Defense Health Agency
Core 1: Specimen and Data Core
$387,261Paul Nghiem · University Of Washington · P01 · FY2021 · CA
Regulation of Macrophage- and Microglia-mediated STING Signaling in Glioblastoma
$387,254Rongze Olivia Lu · University Of California, San Francisco · R01 · FY2023 · NS
DNA damaging therapy and immune response in small cell lung cancer subtypes
$387,250Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
DNA damaging therapy and immune response in small cell lung cancer subtypes
$387,250Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Thrombocytes in Cancer Immunity
$387,236Zihai Li · Medical University Of South Carolina · R01 · FY2016 · CA
Thrombocytes in Cancer Immunity
$387,236Zihai Li · Medical University Of South Carolina · R01 · FY2018 · CA
Thrombocytes in Cancer Immunity
$387,236Zihai Li · Medical University Of South Carolina · R01 · FY2015 · CA
Thrombocytes in Cancer Immunity
$387,236Zihai Li · Medical University Of South Carolina · R01 · FY2017 · CA
MULTI-EPITOPE MELANOMA VACCINES FOR CD4 AND CD8 T-CELLS
$387,223Craig Lee Slingluff · University Of Virginia · R01 · FY2008 · CA
Cellular Immunotherapy of Ovarian Cancer
$387,206Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Cellular Immunotherapy of Ovarian Cancer
$387,206Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods
$387,195Stephen J Salipante · University Of Washington · R33 · FY2020 · CA
Pathogensis of Bacterial corneal infection
$387,186Gerald B Pier · Brigham And Women'S Hospital · R01 · FY2012 · EY
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
$387,183Peter A Cohen · Mayo Clinic Rochester · P50 · FY2017 · CA
Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation
$387,083Qin Feng · University Of Houston · R33 · FY2020 · AI